Here are four takeaways:
1. Prohesion is an activated type I collagen wound filler indicated for surgical wound management.
2. The technology is patented and uses type I collagen fragments that have been sheared down to an optimal size.
3. It is in a powder format that allows for complete and liberal coverage of surgical wounds.
4. BioStructures is focused on developing proprietary platforms in bioresorbable bone graft products for a number of spinal and orthopedic fusion procedures.
More articles on devices:
5 things to know about ApiFix’s new board chairman Ted Bird
Mazor appoints Chad Zaring vice president of national accounts — 5 key notes
SpineGuard launches public offering, buoys growth strategy — 8 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
